Ali-Jackson Kamil

CIK 00016543373 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001654337

Recent Transactions

50 trades

Award
PDS Biotechnology Corp$PDSB
Employee Stock Option (Right to Buy)
2025-06-11+22,700→ 22,700 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2025-05-23+3,000→ 3,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2025-05-23+2,500→ 9,375 total
Award
PDS Biotechnology Corp$PDSB
Employee Stock Option (Right to Buy)
2024-06-24+9,000→ 9,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2024-05-25+30,000→ 30,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2024-05-25+25,000→ 68,750 total
Award
PDS Biotechnology Corp$PDSB
Employee Stock Option (Right to Buy)
2023-07-14+9,000→ 9,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2023-05-26+30,000→ 30,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2023-05-26+25,000→ 43,750 total
Award
PDS Biotechnology Corp$PDSB
Stock Option (Right to Buy)
2022-06-28+9,000→ 9,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2022-05-20+22,500→ 22,500 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2022-05-20+18,750→ 18,750 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-01-03+6,638→ 153,114 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-01-03+7,100→ 160,214 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-01-03−27,905→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Unit
2022-01-03−6,638→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-01-03+27,905→ 146,476 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2022-01-03+3,875→ 118,571 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-01-03−7,100→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2022-01-03−3,875→ 0 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2021-12-16+120,000→ 120,000 total
Award
PDS Biotechnology Corp$PDSB
Stock Option (Right to Buy)
2021-06-17+9,000→ 9,000 total
Purchase
PDS Biotechnology Corp$PDSB
Common Stock
2021-06-15$8.50/sh+11,764→ 11,764 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-03$21.96/sh−9,492→ 122,196 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-02$22.31/sh−2,387→ 131,688 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-02$22.32/sh−2,517→ 146,807 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-02$21.50/sh−12,483→ 149,324 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-02$21.51/sh−12,732→ 134,075 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Restricted Stock Units
2021-06-01−33,189→ 0 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-01$22.72/sh−9,746→ 167,061 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-01$23.57/sh−5,254→ 161,807 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-06-01+33,189→ 176,807 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-07$23.99/sh−2,100→ 143,618 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-07$23.23/sh−3,316→ 145,718 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2021-05-07−5,416→ 0 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-07$10.66/sh+5,416→ 149,034 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-06$23.32/sh−11,898→ 146,720 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2021-05-06−15,000→ 5,416 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-06$10.66/sh+15,000→ 158,618 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-06$23.86/sh−3,102→ 143,618 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-05$23.97/sh−14,502→ 144,116 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2021-05-05−15,000→ 20,416 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-05$24.36/sh−498→ 143,618 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-05$10.66/sh+15,000→ 158,618 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-04$23.61/sh−13,721→ 144,897 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-04$10.66/sh+15,000→ 158,618 total
Exercise/Conversion
Aclaris Therapeutics, Inc.$ACRS
Employee Stock Option (Right to Buy)
2021-05-04−15,000→ 35,416 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-04$24.47/sh−1,279→ 143,618 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-03$24.46/sh−10,661→ 147,957 total
Sale
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2021-05-03$24.91/sh−4,339→ 143,618 total

Companies

Recent Filings

Address

C/O RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov